MIRA INFORM REPORT

 

 

Report Date :

23.07.2013

 

 

IDENTIFICATION DETAILS

 

Name :

UNIVERSAL INTEGRATED CORP.

 

 

Registered Office :

5F., No.129, Sec. 1, Fuxing S. Rd., Da-An District, Taipei City 10666

 

 

Country :

Taiwan 

 

 

Date of Incorporation :

07.08.1986

 

 

Com. Reg. No.:

22180049

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Trading of pharmaceutical products, cosmetic and etc.

 

 

No. of Employees :

About 200 Employees

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Taiwan

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

TAIWAN - ECONOMIC OVERVIEW

 

Taiwan has a dynamic capitalist economy with gradually decreasing government guidance of investment and foreign trade. Exports, led by electronics, machinery, and petrochemicals have provided the primary impetus for economic development. This heavy dependence on exports exposes the economy to fluctuations in world demand. In 2009, Taiwan's GDP contracted 1.8%, due primarily to a 13.1% year-on-year decline in exports. In 2010 GDP grew 10.7%, as exports returned to the level of previous years, and in 2011, grew 4.0%. In 2012, however, growth fell to 1.3%, because of softening global demand. Taiwan's diplomatic isolation, low birth rate, and rapidly aging population are major long-term challenges. Free trade agreements have proliferated in East Asia over the past several years, but except for the landmark Economic Cooperation Framework Agreement (ECFA) signed with China in June 2010, so far Taiwan has been excluded from this greater economic integration in part because of its diplomatic status. Negotiations continue on such follow-on components of ECFA regarding trade in goods and services. The MA administration has said that the ECFA will serve as a stepping stone toward trade pacts with other key trade partners, which Taiwan subsequently launched with Singapore and New Zealand. Taiwan's Total Fertility rate of just over one child per woman is among the lowest in the world, raising the prospect of future labor shortages, falling domestic demand, and declining tax revenues. Taiwan's population is aging quickly, with the number of people over 65 accounting for 11.2% of the island's total population as of 2012. The island runs a large trade surplus largely because of its surplus with China, and its foreign reserves are the world's fifth largest, behind China, Japan, Saudi Arabia, and Russia. In 2006 China overtook the US to become Taiwan's second-largest source of imports after Japan. China is also the island's number one destination for foreign direct investment. Three financial memorandums of understanding, covering banking, securities, and insurance, took effect in mid-January 2010, opening the island to greater investments from the mainland's financial firms and institutional investors, and providing new opportunities for Taiwan financial firms to operate in China. In August 2012, Taiwan Central Bank signed a memorandum of understanding on cross-Strait currency settlement with its Chinese counterpart. The MOU allows for the direct settlement of Chinese RMB and the New Taiwan dollar across the Strait, which could help develop Taiwan into a local RMB hub. Closer economic links with the mainland bring greater opportunities for the Taiwan economy, but also poses new challenges as the island becomes more economically dependent on China while political differences remain unresolved.

Source : CIA


Contact Points

 

Company Name:

Universal Integrated Corp.

Supplied Name:

Universal Integrated

Trading Address:

5F., No.129, Sec. 1, Fuxing S. Rd., Da-An District, Taipei City 10666, Taiwan (R.O.C.)

Supplied Address:

5F, No 129 Sec 1 Fuxing S Road Da-An District Taipei City

Telephone Number:

+886-2-2752-3235

Fax Number:

+886-2-2775-5257

Notes: The exact name and address are as above.

 

Credit Summary

 

Credit Opinion:

Business connections are permissible.

 

Company Identification Details

 

Registered Name:

Universal Integrated Corp.

Registered Address:

5F., No.129, Sec. 1, Fuxing S. Rd., Da-An District, Taipei City 10666, Taiwan (R.O.C.)

Date of Foundation:

1986-8-7

Registration Number:

22180049

Registry:

Taipei City Government

Registered Capital:

NTD 60,000,000 (USD 2,010,000)

(As of 2013.07, 1 NTD = 0.0335 USD)

Paid-up Capital:

NTD 40,000,000 (USD 1,340,000 )

Legal Representatives:

Xiejun Qiu

Legal Form:

Joint Stock Company

Principal Activities:

Trading of pharmaceutical products, cosmetic and etc.

Staff:

About 200 Employees

Listed at Stock Exchange:

No

Date of Last Annual Return:

2013-7-10

 

History

Subject was incorporated on 1986-8-7 with registered number 22180049 as Joint Stock Company in Taiwan.

 

Shareholders

 

           

Name

Subscription Shares

Xiejun Qiu

975,000

Shenxia Song

770,600

Weizhong Qiu

237,200

Weiqun Qiu

237,077

 

The information above is that of subject’s major shareholders.

 

Subsidiaries & Branches

 

Related Companies

1

Name

Giant & Medcom Corp.

Address

5F., No.127, Sec. 1, Fu-Hsing S. Rd., Da-An District, Taipei City 10666, Taiwan (R.O.C.)

Registered Number

30939019

Date of Foundation

1981-3-11

Telephone Number

+886-2-2753-3235

2

Name

Chin An Trade Corporation ( Liberal Translated)

Address

Room 5, 11 Floor, No.33 Sec2 Jianguo North Road, Zhongshan District, Taipei

Telephone Number

+886-27523237

3

Name

Mai Tong Corporation ( Liberal Translated)

Address

5F., No.129, Sec. 1, Fuxing S. Rd., Da-An District, Taipei City 10666, Taiwan (R.O.C.)

 

Personnel Information

 

Core Management

 

Directors

1

Name

Xiejun Qiu

Position

Board Chairman

2

Name

Shenxia Song

Position

Director

3

Name

Weizhong Qiu

Position

Director

4

Name

Weiqun Qiu

Position

Supervisor

 

Personnel Structure

 

Total Employees

About 200 Employees

 


Operation Information

 

Offices & Factories

 

 

Headquarters

Add

5F., No.129, Sec. 1, Fuxing S. Rd., Da-An District, Taipei City 10666, Taiwan (R.O.C.)

 

Production Information

 

l         The subject is a trader of pharmaceutical products, cosmetic and etc.

 

Purchase Information

 

l         The registered activities of subject:

Business Code

Details

F108011

Wholesales of traditional Chinese medicine.

F108021

Wholesales of western medicine.

F208011

Retails of traditional Chinese medicine.

F208021

Retails of western medicine.

F108031

Wholesales of medical equipment.

F208031

Retails of medical equipment.

F401021

Importing of radio-frequency devices for licensed telecommunication.

F113070

Wholesales of telecommunication equipment.

F213060

Retails of telecommunication equipment.

E605010

Installing of computer equipment.

F113050

Wholesales of computer and transactional machinery and equipment.

F213030

Retails of computer and transactional machinery and equipment.

F108040

Wholesales of cosmetic.

F208040

Retails of cosmetic.

F102170

Wholesales of food and other good.

F203010

Retails of food and drinks.

F102040

Wholesales of drinks.

F401010

International trading business.

F107080

Wholesales of environmental medicine.

J305010

Publishing of talkies.

F104110

Wholesales of cloth, wearing, shoe, cap, umbrella and accessories for apparels.

F204110

Retails of cloth, wearing, shoe, cap, umbrella and accessories for apparels.

J303010

Publishing of magazine.

ZZ99999

Besides licensed business, all other business items those are not banned or restricted.

 

l         It is introduced that subject purchases its products from Europe, America, Japan, and Taiwan, etc.

 

Sales Information

 

l         It is introduced that subject is mainly engaged in sales of pharmaceutical products, cosmetic and etc.

l         It is introduced that subject’s selling territory is mainly in Taiwan domestic market.

l         It is introduced that subject’s major customers are hospitals, healthcare center, supermarkets  and etc.

l         It is introduced that subject is an agent of many brands, such as “Xanthium”, “Erispan”, “Salagen”, “Fleet”, “Summers Eve”, and “FlexNow” and etc.

 

Major products sold

Brand

Function

Original

Fleet Enema

Purging gut

America

Polyxal

Restoring scar

--

Xanthium

Depressing respiratory tract obstruction

--

Urinom

Depressing uric acid

Japan

Progor

Resisting high blood pressure

Belgium

Acure

Treating acne

America

Salagen

Treating mouth dry disease

America

Erispan

Resisting dysphoria

--

Fenogal

Depressing blood-fat

Belgium

Summer’s eve

Cleaning vagina

America

Sensimin

Skin care

Japan

Gyn hydralin

Cleaning skin

Taiwan

 

Import and export right:

Import right

Yes

Export right

Yes

 

Settlements

 

Purchase

 

Domestic Purchase

Product

Payment Terms

Proportion

Pharmaceutical products, cosmetic and etc.

COD, CBD, etc

100%

 

Foreign Purchase

Product

Payment Terms

Proportion

Pharmaceutical products, cosmetic and etc.

CBD, etc

100%

 

 

Sales

 

Domestic Markets (Taiwan)

Product

Sales Terms

Proportion

Pharmaceutical products, cosmetic and etc.

COD, CBD, etc

100%

 

Export

 

The subject has little export.

 

Financial Information

 

Subject has no obligations to disclose its financial statements to the third party according to the relevant policy in Taiwan and the only source from which we can obtain the information is the subject itself.

Subject’s relevant staff Ms. Guo declined to disclose its financials citing the grounds of company’s confidentiality; from other source we can not obtain the relevant information, either.

 

Bankers

 

Subject declined to disclose its bank details; from other source we cannot obtain the relevant information, either.

 

Public Record

 

Mortgage

 

No chattel mortgage record of subject has been found within the recent 3 months.

 

 

 

Lawsuit

 

Trial Number:

2008,Beijian,4482

Date of Trial:

2008-3-14

Reason:

Payment for goods

 

Interview Details

 

Name

Ms. Guo

Department

Sales Department

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.59.41

UK Pound

1

Rs.90.74

Euro

1

Rs.78.11

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.